The
interleukin 1beta converting enzyme (
ICE) family plays a pivotal role in programmed cell death and has been implicated in
stroke and
neurodegenerative diseases. During reperfusion after filamentous
middle cerebral artery occlusion,
ICE-like cleavage products and tissue immunoreactive
interleukin 1beta (IL-1beta) levels increased in ischemic mouse brain. Ischemic injury decreased after intracerebroventricular
injections of
ICE-like
protease inhibitors, N-
benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (
z-VAD.FMK), acetyl-Tyr-Val-
Ala-Asp-chloromethylketone, or a relatively selective inhibitor of CPP32-like
caspases, N-benzyloxycarbonyl-
Asp-Glu-Val-Asp-fluoromethylketone, but not a
cathepsin B inhibitor, N-benzyloxycarbonyl-
Phe-Ala-fluoromethylketone.
z-VAD.FMK decreased
ICE-like cleavage products and tissue immunoreactive IL-1beta levels in ischemic mouse brain and reduced tissue damage when administered to rats as well. Only
z-VAD.FMK and acetyl-Tyr-Val-
Ala-Asp-chloromethylketone reduced
brain swelling, and N-benzyloxycarbonyl-
Asp-Glu-Val-Asp-fluoromethylketone did not attenuate the
ischemia-induced increase in tissue IL-1beta levels. The three
cysteine protease inhibitors significantly improved behavioral deficits, thereby showing that functional recovery of ischemic neuronal tissue can follow blockade of
enzymes associated with apoptotic cell death. Finally, we examined the effect of
z-VAD.FMK on excitotoxicity and found that it protected against alpha-amino-3-hydroxy-5-methyl-4-isoxazole
propionate-induced or to a lesser extent
N-methyl-D-aspartate-induced excitotoxic brain damage. Thus,
ICE-like and CPP32-like
caspases contribute to mechanisms of cell death in ischemic and excitotoxic
brain injury and provide therapeutic targets for
stroke and neurodegenerative brain damage.